Does health-related quality of life (HRQL) improve for patients who respond to chemotherapy? Analysis of patients with advanced pancreas cancer (APC) receiving gemcitabine on Cancer and Leukemia Group B (CALGB) study #80303

D. Romanus,L Archer,Xiaofei Wang,Richard M. Goldberg,Mary F. Mulcahy,Hedy L. Kindler,Deborah Schrag

Does health-related quality of life (HRQL) improve for patients who respond to chemotherapy? Analysis of patients with advanced pancreas cancer (APC) receiving gemcitabine on Cancer and Leukemia Group B (CALGB) study #80303

2016

D. Romanus
L Archer
Xiaofei Wang
Richard M. Goldberg
Mary F. Mulcahy
Hedy L. Kindler
Deborah Schrag

9008 Background: Gemcitabine chemotherapy for APC is palliative and confers only modest survival advantage. Therefore HRQL concerns are of paramount importance. Methods: We compared HRQL scores bas...

Keywords:

Gemcitabine
Pancreas
Quality of life
Group B
Internal medicine
Cancer
Leukemia
Oncology
Medicine
Chemotherapy
Physical therapy
survival advantage
health related quality of life

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations